REQUEST A DEMO
Total
USD $0.00
Search more companies

TWI Biotechnology, Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: TWI Biotechnology, Inc. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

TWI Biotechnology, Inc. is an enterprise located in Taiwan, China, with the main office in Taipei City. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on July 16, 2010. It currently has a total number of 21 (2023) employees. During that time, TWI Biotechnology, Inc.’s total assets grew by 56.92%.

Headquarters
8F, No.41, Lane 221, Kang Chien Rd, Nei Hu Dist
Taipei City; Taipei City;

Contact Details: Purchase the TWI Biotechnology, Inc. report to view the information.

Website: http://www.twibiotech.com

Basic Information
Total Employees:
Purchase the TWI Biotechnology, Inc. report to view the information.
Outstanding Shares:
Purchase the TWI Biotechnology, Inc. report to view the information.
Financial Auditors:
Purchase the TWI Biotechnology, Inc. report to view the information.
Incorporation Date:
July 16, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
60.17%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
TERM DEPOSIT
0.76%
Time Deposit-USD Time Deposit
0.76%
Company Performance
Financial values in the chart are available after TWI Biotechnology, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-143.92%
EBITDA
-184.14%
Net Profit (Loss) for the Period
-137.32%
Total assets
56.92%
Total equity
47.44%
Return on Equity (ROE)
-15%
Quick Ratio
-0.63%
Cash Ratio
-1.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?